Anzeige
Mehr »
Montag, 26.01.2026 - Börsentäglich über 12.000 News
KI braucht Kupfer: Kupfer-Engpass trifft jetzt auf starke Rohstoffhausse
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

S&P 500 

WKN:  ISIN: US78378X1072 
S&P 500
23.01.26 | 22:00
6.914,75
+0,04 % +3,09
1-Jahres-Chart
S&P 500 Chart 1 Jahr
5-Tage-Chart
S&P 500 5-Tage-Chart
Markt oder Branche auswählen:

Aktuelle News zu Aktien im S&P 500

  • 24 h
  • 7 Tage
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:  Alle DE EN
LeserMedien
02:39S. Korea to hold annual consultations with Moody's on sovereign credit rating4
02:30Baker Hughes Q4 Results Top Estimates; Stock Climbs In Overnight Trading86WASHINGTON (dpa-AFX) - Baker Hughes Company (BKR) reported that its net income attributable to the company for the fourth-quarter declined to $876 million or $0.88 per share from $1.179 billion...
► Artikel lesen
02:29Baker Hughes Q4 Results Top Estimates; Stock Climbs In Overnight Trading3
02:22GM Korea Labor Dispute Intensifies Amid Service Center Closures4
02:17CN In Principle Approves BABA-W, TENCENT, ByteDance to Purchase NVIDIA H200 Chips: Wire3
02:14Intel Reportedly Presents First Thick-Core Glass Substrate with EMIB, Targeting AI Data Centers3
01:38HKTDC, Microsoft Launch AI Programme for SMEs in Hong Kong3
00:59Samsung Elec to start production of HBM4 chips next month for Nvidia supply, source says3
00:42Microsoft Research Unveils Rho-Alpha Robotics Model To Bring Physical AI To Real-World Manipulation4
00:42GM To Shift Buick Envision Production From China To U.S.2
00:38Inflation up in Japan in 2026, faster output growth: S&P Global2
00:38S&P Global expects slowdowns in China, India, UK, eurozone in 20265
00:38Salesforce tries to keep a lid on 'agentic sprawl' through MuleSoft Agent Fabric4
00:36Biogen Inc.: FDA Accepts LEQEMBI IQLIK (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease under Priority Review2
00:26Korea emerges as Google Gemini's second-largest revenue market2
00:15Medtronic calls for 'deescalation' after federal agents kill nurse2
00:05Oilfield service company Baker Hughes posts 11% rise in adjusted quarterly profit6
00:05Uber and DoorDash Lose Bid to Quash NYC Tipping Law3
00:01Billionaire David Tepper Sells Oracle, Micron, and Intel, and Buys an AI Stock Up 31,000% Since Its IPO14
00:01Walmart vs. Target: Which Is the Better Long-Term Play?4
Weiter >>